1. Effect of Sunitinib Treatment on Skin Sodium Accumulation in Patients With Renal Cancer: a Pilot Study.
- Author
-
Marko, Lajos, Dorr, Anne, Linz, Peter, van den Meiracker, Anton H., Garrelds, Ingrid M., Kuehne, Titus, Dechend, Ralf, Danser, A. H. Jan, Florcken, Anne, Muller, Dominik N., Markó, Lajos, Dörr, Anne, Flörcken, Anne, and Müller, Dominik N
- Abstract
Intermitting... Although the here presented data are derived from a small number of subjects we could verify earlier findings of sunitinib treatment on blood pressure and on circulating endothelin-1 and VEGF levels.[5],[6] More importantly, it was enough powered to detect clear changes in skin sodium content and in plasma VEGF-C concentrations; sunitinib treatment decreased VEGF-C levels and led to an increase of skin sodium content. In contrast to VEGF-A, high baseline VEGF-C concentrations dropped after sunitinib treatment and stayed low independently from further treatment phase of sunitinib (Figure [F]). Our findings also suggest that whereas a side-effect such as blood pressure elevation is a reversible phenomenon of a sunitinib treatment, it could have a long-lasting effect on plasma VEGF-C concentrations and thereby on skin sodium homeostasis. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF